Roche Holding AG (RHHBY)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Severin Schwan Ph.D. | Executive Chairman | 8.92M | -- | 1967 |
| Dr. Thomas Schinecker | Chief Executive Officer | 4.6M | -- | 1975 |
| Dr. Alan Hippe | Chief Financial & Information Officer | 4.88M | -- | 1967 |
| Dr. Bruno Eschli | Head of Investor Relations | -- | -- | -- |
| Ms. Claudia Bockstiegel | General Counsel | -- | -- | 1964 |
| Ms. Pascale Schmidt | Chief Compliance Officer | -- | -- | 1973 |
| Ms. Barbara Schadler | Head of Group Communications | -- | -- | 1962 |
| Ms. Cristina A. Wilbur | Chief People Officer | 3.47M | -- | 1967 |
| Dr. Nicolas Dunant | Head of Group Media Relations | -- | -- | -- |
| Mr. Boris L. Zaitra | Head of Corporate Business Development | -- | -- | 1972 |
Roche Holding AG
- Sector:?
- Healthcare
- Industry:? Drug Manufacturers - General
- Full Time Employees:?
- 103,605
Description
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.
Corporate Governance
Upcoming Events
January 30, 2025 at 6:00 AM UTC
Roche Holding AG Earnings Date
Recent Events
May 3, 2024 at 12:00 AM UTC
Dividend Date
March 14, 2024 at 12:00 AM UTC
Ex-Dividend Date